Berberine

Health-Grail Berberine is a dual-extract capsule supplement containing 790 milligrams of Berberine Hydrochloride Extract standardized to 8% and 10 milligrams standardized to 97% per two-capsule serving.

No. The 800-milligram total represents the combined weight of two extracts with different standardization percentages. It should not be described as 800 milligrams of pure active Berberine HCl.

The current label lists two extract weights and their standardization percentages but does not state one combined active-berberine total. Health-Grail should confirm the exact active yield with the manufacturer and current certificate of analysis.

The current Supplement Facts panel defines one serving as two capsules.

Each bottle contains 60 capsules and provides approximately 30 servings at the labeled serving size of two capsules.

Berberine is a naturally occurring plant compound found in species such as barberry, goldenseal, Oregon grape, goldthread, and tree turmeric.

Berberine has been studied for possible effects on glucose and lipid metabolism. It should be positioned as metabolic-wellness support rather than a treatment for diabetes, high cholesterol, obesity, or another medical condition.

Berberine has affected AMPK-related pathways in preclinical and some human research. The current finished product should not promise a guaranteed level of AMPK activation or describe AMPK as a biological switch that automatically creates weight loss.

No supplement has been proven to reproduce all physiological effects of fasting, cardiovascular exercise, resistance training, or improved fitness.

Some studies in people with type 2 diabetes have reported modest improvements in glucose-related measurements. Berberine is not a diabetes treatment and should not replace medication, monitoring, nutrition, or medical care.

Do not combine Berberine with insulin or glucose-lowering medication without guidance from the treating healthcare professional. Combined use may cause blood glucose to fall too low.

Some studies have reported modest lipid changes, but the evidence varies in quality. Berberine should not replace statins, lipid testing, nutrition changes, or clinician-directed cardiovascular treatment.

Current research is not conclusive. Berberine should not be promoted as a guaranteed weight-loss product, fat burner, or substitute for nutrition, activity, sleep, or medical treatment.

No. Berberine is not equivalent to semaglutide or another prescription GLP-1 medication and should not be marketed as “nature’s Ozempic.”

The current label does not list caffeine or another conventional stimulant, so customers should not expect an immediate energy or focus sensation.

The product should not promise that carbohydrates will be directed into muscle rather than stored as fat. Nutrient handling depends on training, total calorie intake, glycogen status, insulin response, and many other factors.

Follow the directions printed on the physical bottle and individualized guidance from a healthcare professional. Medication schedules, gastrointestinal tolerance, and blood-glucose monitoring may affect timing.

Follow the physical product label and discuss ongoing use with a healthcare professional. Long-term use requires additional care when medications, chronic conditions, or glucose monitoring are involved.

Yes. Berberine may affect CYP2D6, CYP2C9, CYP3A4, drug transporters, and medicines including cyclosporine and tacrolimus. Review every medication with a physician or pharmacist.

Transplant recipients should not begin Berberine without approval from their transplant team. Berberine may increase cyclosporine or tacrolimus exposure and contribute to toxicity.

No. Berberine should not be used during pregnancy or breastfeeding because exposure may harm the fetus or infant and can worsen newborn jaundice.

Berberine should not be given to infants. Use in children should occur only under the direction and monitoring of a qualified pediatric healthcare professional.

Reported effects include nausea, abdominal discomfort, bloating, constipation, diarrhea, appetite changes, rash, dizziness, and weakness.

The current label lists cellulose vegetable capsules. Customers with strict dietary requirements should verify the complete physical label and current sourcing documentation.

Yes. The other-ingredients panel lists microcrystalline cellulose, L-Leucine, and olive oil in addition to the vegetable capsule.

No. Supplements should complement—not replace—balanced nutrition, resistance training, cardiovascular exercise, sleep, stress management, medical testing, medication, and clinician-directed care.